Healthcare & Life Sciences

AVEO Pharmaceuticals, Inc.

United States
alivepre-ipo
Sign in to unlock
pre-ipo
Stage

About

AVEO Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company focused on developing targeted medicines for oncology and other unmet medical needs, retaining North American rights to its oncology portfolio while partnering for global commercialization.

Explore AVEO Pharmaceuticals, Inc.'s full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing